Lexaria Bioscience Corp (NQ: LEXX )
3.380
+0.290
(+9.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Lexaria Bioscience Corp
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 28, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 27, 2024
Via Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering
February 27, 2024
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2024/1_3.png?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program
January 16, 2024
Via ACCESSWIRE
Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering
February 27, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on $3.6M Registered Direct Offering
February 15, 2024
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
February 09, 2024
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria's Submits Investigational New Drug Application
January 30, 2024
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Lexaria Releases Annual Letter from the CEO
January 24, 2024
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program
January 16, 2024
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.